RELAPSED / REFRACTORY OSTEOSARCOMA

Clinical trials for RELAPSED / REFRACTORY OSTEOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new RELAPSED / REFRACTORY OSTEOSARCOMA trials appear

Sign up with your email to follow new studies for RELAPSED / REFRACTORY OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Targeted radiation weapon tested against tough bone cancer

Disease control Recruiting now

This study is testing a new drug called LNTH-2403 for people whose osteosarcoma (a type of bone cancer) has come back or hasn't responded to standard chemotherapy. The drug is designed to deliver radiation directly to cancer cells using a special targeting system. Researchers wil…

Matched conditions: RELAPSED / REFRACTORY OSTEOSARCOMA

Phase: PHASE1, PHASE2 • Sponsor: Lantheus Medical Imaging • Aim: Disease control

Last updated Mar 24, 2026 12:03 UTC

RELAPSED / REFRACTORY OSTEOSARCOMA

Get alerted when new RELAPSED / REFRACTORY OSTEOSARCOMA trials appear

Targeted radiation weapon tested against tough bone cancer